| Minsu Kwak, MD | |
|
2601 Ocean Pkwy, Brooklyn, NY 11235-7745 | |
| (718) 616-3000 | |
| Not Available |
| Full Name | Minsu Kwak |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 2601 Ocean Pkwy, Brooklyn, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033772785 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 61330431 (Washington) | Primary |
| Entity Name | Signify Health Medical Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750845863 PECOS PAC ID: 2163764424 Enrollment ID: O20191230002111 |
News Archive
The cat is finally out of the bag with two official reports revealing those most at risk from the excessive consumption of alcohol in Britain are top bosses and children.
COVID-19 disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a highly infectious disease. As of today, over 170,000 people worldwide have succumbed to the infection. Reports have shown that some comorbidities and illnesses raise the risk of getting infected and also influence the severity of the disease. Having a compromised immune system can also drastically raise the risk of getting COVID-19.
Public service advertising campaigns that use guilt or shame to warn against alcohol abuse can actually have the reverse effect, spurring increased drinking among target audiences, according to new research from the Indiana University Kelley School of Business.
Antisense Therapeutics Limited is pleased to advise that results from a chronic toxicity study in monkeys indicate that ATL1102, an antisense oligonucleotide currently under development for the treatment of multiple sclerosis (MS), was well-tolerated when given subcutaneously for a 6-month dosing period at the 2 dose levels tested (1.5 and 3mg/kg/dose).
Merck announced the presentation of new analyses of efficacy and safety data for investigational Cladribine Tablets in poster presentations at the Annual Meeting of the American Academy of Neurology (AAN), that took place April 22 – 28, 2017, in Boston, Massachusetts.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Minsu Kwak, MD 626 120th Ave Ne Ste B201, Bellevue, WA 98005-3038 Ph: () - | Minsu Kwak, MD 2601 Ocean Pkwy, Brooklyn, NY 11235-7745 Ph: (718) 616-3000 |
News Archive
The cat is finally out of the bag with two official reports revealing those most at risk from the excessive consumption of alcohol in Britain are top bosses and children.
COVID-19 disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a highly infectious disease. As of today, over 170,000 people worldwide have succumbed to the infection. Reports have shown that some comorbidities and illnesses raise the risk of getting infected and also influence the severity of the disease. Having a compromised immune system can also drastically raise the risk of getting COVID-19.
Public service advertising campaigns that use guilt or shame to warn against alcohol abuse can actually have the reverse effect, spurring increased drinking among target audiences, according to new research from the Indiana University Kelley School of Business.
Antisense Therapeutics Limited is pleased to advise that results from a chronic toxicity study in monkeys indicate that ATL1102, an antisense oligonucleotide currently under development for the treatment of multiple sclerosis (MS), was well-tolerated when given subcutaneously for a 6-month dosing period at the 2 dose levels tested (1.5 and 3mg/kg/dose).
Merck announced the presentation of new analyses of efficacy and safety data for investigational Cladribine Tablets in poster presentations at the Annual Meeting of the American Academy of Neurology (AAN), that took place April 22 – 28, 2017, in Boston, Massachusetts.
› Verified 9 days ago
Allix Megan Hillebrand, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: Maimonides Medical Center, 4802 10th Avenue, Brooklyn, NY 11219 Phone: 718-283-8000 | |
Matthew Silverman, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5925 15th Ave, Brooklyn, NY 11219 Phone: 718-972-2700 Fax: 718-972-2701 | |
Viktoriya Bakcheva, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1599 West 6 Street, Brooklyn, NY 11204 Phone: 718-360-5014 Fax: 718-360-2314 | |
Mary Fatehi, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 97 Amity St Fl 3, Obgyn Associates At Lich, Brooklyn, NY 11201 Phone: 718-780-1231 Fax: 718-780-4987 | |
Dr. Bala Krishna Babji Ravi, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 374 Stockholm St, C/o Faculty Practice, Brooklyn, NY 11237 Phone: 718-963-6551 Fax: 718-963-6793 | |
Dr. Ling Zhu, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 730 58th St, Brooklyn, NY 11220 Phone: 347-382-0338 | |
Dr. Nikolaos Kiouranakis, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1012 Avenue Y, Brooklyn, NY 11235 Phone: 718-879-8877 Fax: 718-879-8866 |